BCL-6 protein is expressed in germinal-center B cells - PubMed (original) (raw)
. 1995 Jul 1;86(1):45-53.
Affiliations
- PMID: 7795255
Free article
BCL-6 protein is expressed in germinal-center B cells
G Cattoretti et al. Blood. 1995.
Free article
Abstract
Structural alterations of the 5' noncoding region of the BCL-6 gene have been found in 40% of diffuse large cell lymphoma (DLCL) and 5% to 10% of follicular lymphomas (FL), suggesting that deregulated BCL-6 expression may play a role in lymphomagenesis. Nucleotide sequencing of BCL-6 cDNA predicted a protein containing six zinc-finger domains, suggesting that it may function as a transcription factor. Using antisera raised against N- and C-terminal BCL-6 synthetic oligopeptides in immunoprecipitation, immunoblot, and immunocytochemical assays, this study identifies the BCL-6 gene product as a 95-kD nuclear protein. Western blot analysis of human tumor cell lines representative of various hematopoietic lineages/stages of differentiation showed that the BCL-6 protein is predominantly expressed in the B-cell lineage where it was found in mature B cells. Immunohistochemical analysis of normal human lymphoid tissues indicated that BCL-6 expression is topographically restricted to germinal centers including all centroblasts and centrocytes. The BCL-6 protein was also detectable in inter- and intra-follicular CD4+ T cells, but not in other follicular components including mantle-zone B cells, plasma cells, dendritic cells, and macrophages. Immunohistochemical analysis of DLCL and FL biopsy samples showed that the BCL-6 protein is detectable in these tumors independent of the presence of BCL-6 gene rearrangements. These results indicate that the expression of the BCL-6 gene is specifically regulated during B-cell differentiation and suggest a role for BCL-6 in germinal center development or function. Because DLCL derive from germinal-center B cells, deregulated BCL-6 expression may contribute to lymphomagenesis by preventing postgerminal center differentiation.
Similar articles
- BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.
Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, Sato K, Kato T, Ota H, Mori S. Onizuka T, et al. Blood. 1995 Jul 1;86(1):28-37. Blood. 1995. PMID: 7795234 - Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES, Raffeld M. Krenacs L, et al. Blood. 1998 Aug 15;92(4):1308-16. Blood. 1998. PMID: 9694719 - Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
Falini B, Fizzotti M, Pileri S, Liso A, Pasqualucci L, Flenghi L. Falini B, et al. Ann Oncol. 1997;8 Suppl 2:101-4. Ann Oncol. 1997. PMID: 9209651 Review. - Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
Ree HJ, Yang WI, Kim CW, Huh J, Lee SS, Cho EY, Ko YH, Charney D. Ree HJ, et al. Hum Pathol. 2001 Sep;32(9):954-62. doi: 10.1053/hupa.2001.27118. Hum Pathol. 2001. PMID: 11567225 - BCL-6 and the molecular pathogenesis of B-cell lymphoma.
Dalla-Favera R, Ye BH, Lo Coco F, Chang CC, Cechova K, Zhang J, Migliazza A, Mellado W, Niu H, Chaganti S, et al. Dalla-Favera R, et al. Cold Spring Harb Symp Quant Biol. 1994;59:117-23. doi: 10.1101/sqb.1994.059.01.015. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587061 Review.
Cited by
- GPRASP protein deficiency triggers lymphoproliferative disease by affecting B-cell differentiation.
Morales-Hernández A, Kooienga E, Sheppard H, Gheorghe G, Caprio C, Chabot A, McKinney-Freeman S. Morales-Hernández A, et al. Hemasphere. 2024 Oct 30;8(11):e70037. doi: 10.1002/hem3.70037. eCollection 2024 Nov. Hemasphere. 2024. PMID: 39479518 Free PMC article. - Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression.
SoRelle ED, Haynes LE, Willard KA, Chang B, Ch'ng J, Christofk H, Luftig MA. SoRelle ED, et al. PLoS Pathog. 2024 Oct 24;20(10):e1012341. doi: 10.1371/journal.ppat.1012341. eCollection 2024 Oct. PLoS Pathog. 2024. PMID: 39446925 Free PMC article. - Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.
Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z, Wang X, Huang S, Zhang D, Wu H. Zhao L, et al. Signal Transduct Target Ther. 2024 Aug 28;9(1):225. doi: 10.1038/s41392-024-01947-5. Signal Transduct Target Ther. 2024. PMID: 39198425 Free PMC article. Review. - Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression.
SoRelle ED, Haynes LE, Willard KA, Chang B, Ch'ng J, Christofk H, Luftig MA. SoRelle ED, et al. bioRxiv [Preprint]. 2024 Jun 14:2024.06.14.598975. doi: 10.1101/2024.06.14.598975. bioRxiv. 2024. PMID: 38915538 Free PMC article. Updated. Preprint. - Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment.
Tran MA, Youssef D, Shroff S, Chowhan D, Beaumont KG, Sebra R, Mehrazin R, Wiklund P, Lin JJ, Horowitz A, Farkas AM, Galsky MD, Sfakianos JP, Bhardwaj N. Tran MA, et al. J Exp Med. 2024 Aug 5;221(8):e20240045. doi: 10.1084/jem.20240045. Epub 2024 Jun 7. J Exp Med. 2024. PMID: 38847806
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials